Study guide
10.1 The Febrile Child, Sepsis & Meningococcal Disease
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
10.1 The Febrile Child, Sepsis & Meningococcal Disease
Key Takeaways Explain This Topic AI
The NICE NG143 traffic light system stratifies fever in children under 5 into green, amber and red; red features include a non-blanching rash, bulging fontanelle, neck stiffness, status epilepticus, grunting, RR over 60, reduced skin turgor and appearing ill, while CRT of 3 seconds or more is amber.
Age-specific physiological cut-offs mandate immediate red-flag escalation: any infant aged under 3 months with a temperature ≥38.0°C is automatically high-risk (Red), requiring urgent paediatric admission, a full septic screen (blood cultures, FBC, CRP, clean catch urine microscopy/culture, chest X-ray, and lumbar puncture), and empiric IV cefotaxime plus ampicillin/amoxicillin for Listeria monocytogenes coverage; an infant aged 3–6 months with temperature ≥39.0°C is at least intermediate risk (Amber).
Antipyretics (paracetamol and ibuprofen) should be administered solely to relieve distress and pain in a miserable febrile child, not to achieve normothermia or prevent febrile seizures; never give paracetamol and ibuprofen simultaneously (use monotherapy first, alternating only if distress persists); aspirin is strictly contraindicated in children under 16 due to Reye's syndrome.
Suspected meningococcal disease presenting with a non-blanching purpuric or petechial rash mandates immediate pre-hospital IM or IV benzylpenicillin (or cefotaxime/ceftriaxone if penicillin allergic) without delaying emergency 999 hospital transfer; definitive hospital care includes IV ceftriaxone (80 mg/kg) plus IV dexamethasone in children over 3 months.
Kawasaki disease is an acute systemic medium-vessel vasculitis diagnosed by fever persisting ≥5 days plus at least 4 of 5 classic signs (bilateral non-purulent conjunctivitis, polymorphous exanthem, cervical lymphadenopathy >1.5 cm, oral mucosal changes [strawberry tongue, red cracked lips], and extremity erythema/oedema/periungual desquamation); prompt treatment with single-dose IVIG (2 g/kg) and anti-inflammatory aspirin prevents coronary artery aneurysms.
Last updated: October 2026
The Febrile Child, Sepsis & Meningococcal Disease
Fever is one of the most common presentations in paediatric acute care and general practice. While the vast majority of febrile episodes in children are self-limiting viral infections, acute systemic bacterial infections—such as meningococcal septicaemia, severe bacterial meningitis, urinary tract infections, and occult bacteraemia—can progress with terrifying rapidity. Clinical assessment requires a methodical approach that rapidly identifies high-risk red-flag features while avoiding unnecessary invasive procedures in low-risk children.
The NICE Traffic Light System (NICE NG143)
NICE guideline NG143 ( Fever in under 5s: assessment and initial management ) provides a validated clinical risk stratification tool dividing children presenting with fever into three clinical risk tiers: Green (Low Risk) , Amber (Intermediate Risk) , and Red (High Risk) . A child exhibiting any single red feature is classified as high-risk, and a child with any amber feature (and no red features) is classified as intermediate-risk.
- Assessment Domain Green (Low Risk) Amber (Intermediate Risk) Red (High Risk)
- Colour Normal colour of skin, lips and tongue Pallor reported by parent or carer Pale, mottled, ashen or blue
Activity Responds normally to social cues; content or smiles; stays awake or awakens quickly; strong normal cry or not crying Not responding normally to social cues; no smile; wakes only with prolonged stimulation; decreased activity No response to social cues; appears ill to a healthcare professional ; does not wake, or if roused does not stay awake; weak, high-pitched or continuous cry
Respiratory No amber or red respiratory signs Nasal flaring; tachypnoea (RR > 50/min age 6–12 months; > 40/min age over 12 months); oxygen saturation 95% or less in air ; crackles in the chest Grunting; tachypnoea (RR > 60/min); moderate or severe chest indrawing
Circulation & Hydration Normal skin and eyes; moist mucous membranes Tachycardia (> 160/min under 12 months; > 150/min at 12–24 months; > 140/min at 2–5 years); capillary refill time 3 seconds or more ; dry mucous membranes; poor feeding in infants; reduced urine output Reduced skin turgor
Other None of the amber or red symptoms or signs Age 3–6 months with temperature ≥ 39°C; fever for 5 days or more; rigors; swelling of a limb or joint; non-weight bearing limb or not using an extremity Age < 3 months with temperature ≥ 38°C ; non-blanching rash ; bulging fontanelle ; neck stiffness ; status epilepticus ; focal neurological signs ; focal seizures
Note that in NICE NG143 a capillary refill time of 3 seconds or more is an amber sign , not red; it becomes part of a red picture only alongside other features such as reduced skin turgor or signs of shock. Bile-stained vomiting is a surgical red flag (possible malrotation with volvulus) rather than part of the fever traffic-light table.
Important
Age-Specific Temperature Rules:
Age < 3 months with temperature ≥ 38.0°C: Automatically RED FLAG (High Risk) . Clinical signs of invasive infection in young neonates are notoriously non-specific. Immediate paediatric admission and full septic investigation are mandatory.
Age 3 to 6 months with temperature ≥ 39.0°C: Automatically AMBER FLAG (Intermediate Risk) . Requires minimum baseline workup (full blood count, CRP, and urine microscopy/culture) and close hospital or ambulatory review.
Investigation and Management of the High-Risk Febrile Infant
When an infant younger than 3 months presents with a temperature ≥ 38.0°C, or any child exhibits red-flag features, immediate hospital admission to a paediatric facility is indicated.
Full Paediatric Septic Screen
In infants under 3 months, clinical examination alone cannot reliably rule out occult bacterial meningitis, bacteraemia, or urosepsis. The protocolized septic screen comprises:
Blood Tests: Full blood count (FBC), C-reactive protein (CRP) or procalcitonin, and blood cultures.
Urine Testing: Clean catch sample (or catheter specimen / suprapubic aspiration if clean catch unattainable) for urgent dipstick, microscopy, and bacterial culture.
Lumbar Puncture (LP): Mandatory in all febrile infants aged under 1 month, all unwell infants aged 1–3 months, and any infant under 3 months with a peripheral white cell count < 5 × 10⁹/L or > 15 × 10⁹/L, unless absolute contraindications exist (severe respiratory compromise, haemodynamic instability, local infection at puncture site, or clinical signs of raised intracranial pressure).
Chest Radiograph: Indicated if respiratory rate > 60/min, grunting, chest recession, crackles, or focal auscultatory signs are present.
Empirical Antimicrobial Regimens
Infants < 1 month: Intravenous cefotaxime PLUS intravenous ampicillin (or amoxicillin) to cover Listeria monocytogenes , Group B Streptococcus ( Streptococcus agalactiae ), and Escherichia coli .
Infants 1 to 3 months (unwell or high-risk): Intravenous cefotaxime (or intravenous ceftriaxone) PLUS intravenous ampicillin (if Listeria coverage remains clinically suspected).
Ceftriaxone Caution: Ceftriaxone displaces bilirubin from albumin and can cause biliary sludging; hence, cefotaxime is the preferred cephalosporin in neonates and jaundiced infants .
Symptom Control and Antipyretic Safety
Prescribing antipyretics in febrile children requires strict adherence to evidence-based safety principles:
Purpose of Therapy: Paracetamol and ibuprofen are indicated only to alleviate discomfort and distress in a child who appears unhappy or in pain , never solely to achieve a normal temperature reading.
Febrile Convulsion Myth: Antipyretics do not prevent febrile convulsions and must not be administered for this purpose.
Single-Agent Rule: Start with either oral paracetamol (15 mg/kg every 4–6 hours; max 4 doses/24 hours) OR oral ibuprofen (5–10 mg/kg every 6–8 hours; max 30 mg/kg/day). Do not administer both agents simultaneously.
Alternating Therapy: Consider alternating between the two agents only if distress persists or recurs before the next scheduled dose of the initial agent.
Strict Contraindication of Aspirin: Aspirin must NEVER be given to children under 16 years of age (except in specialized conditions like Kawasaki disease) due to the risk of Reye's syndrome —a fatal condition characterized by acute non-inflammatory encephalopathy and hepatic microvesicular steatosis.
Meningococcal Disease & Purpura Fulminans
Meningococcal disease, caused by Neisseria meningitidis (most commonly serogroups B, W, Y, and C in the UK), encompasses meningococcal meningitis and acute meningococcal septicaemia. Sepsis can trigger rapid microvascular thrombosis, extensive dermal necrosis, and disseminated intravascular coagulation (DIC), termed purpura fulminans .
Non-Blanching Rash & The Tumbler Test
A non-blanching petechial (diameter < 2 mm) or purpuric (diameter ≥ 2 mm) rash that fails to fade under the pressure of a clear glass tumbler is the quintessential hallmark of meningococcal septicaemia.
Petechiae confined strictly to the distribution above the superior vena cava (head and neck) can occasionally follow vigorous coughing or vomiting; however, any petechiae below the nipple line or generalized purpura must be treated as life-threatening meningococcal septicaemia until proven otherwise .
Emergency Pre-Hospital Intervention (GP & Paramedic)
If meningococcal disease is suspected in primary care or by ambulance crews:
Immediate Parenteral Benzylpenicillin: Administer a single dose of intramuscular or intravenous benzylpenicillin immediately (Age < 1 year: 300 mg; Age 1–9 years: 600 mg; Age ≥ 10 years: 1200 mg). If there is a history of severe penicillin anaphylaxis, use IV/IM cefotaxime or ceftriaxone .
Immediate Emergency Transfer: Call 999 for emergency transfer to the nearest emergency department. Never delay urgent transfer to give antibiotics if transfer is immediately available.
Hospital Resuscitation Protocol
Resuscitation: High-flow oxygen, rapid IV/IO access, fluid bolus of 10 mL/kg of crystalloid given rapidly, reassessed after each bolus and repeated if needed, if there are signs of shock (prolonged capillary refill, tachycardia, hypotension).
Empirical Antibiotics: Intravenous ceftriaxone 80 mg/kg once daily (max 4 g/day).
Adjunctive Corticosteroids: Intravenous dexamethasone (0.15 mg/kg QDS for 4 days) administered before or with the first dose of antibiotics in children > 3 months with suspected bacterial meningitis to significantly reduce long-term sensorineural hearing loss and neurological sequelae.
Public Health Notification & Prophylaxis: Meningococcal disease is a notifiable disease. Close household contacts must receive chemoprophylaxis with oral ciprofloxacin (single dose) or oral rifampicin to eradicate nasopharyngeal carriage.
Kawasaki Disease (Mucocutaneous Lymph Node Syndrome)
Kawasaki disease is an acute, self-limiting systemic medium-vessel vasculitis that predominantly affects infants and children under 5 years of age (peak incidence at 1–2 years). Its major clinical importance lies in its predilection for the coronary arteries, causing coronary artery aneurysms in 20% to 25% of untreated patients , which can lead to myocardial infarction, ischaemic cardiomyopathy, or sudden cardiac death.
Classic Diagnostic Criteria
The diagnosis is clinical and requires persistent high fever for ≥ 5 days PLUS at least 4 out of the 5 following principal features:
Bilateral Non-Exudative Bulbar Conjunctivitis: Sparing the limbus (the avascular border around the cornea); painless and free of purulent discharge.
Oral Mucosal Changes: Injected, dry, fissured, bleeding erythematous lips; diffuse oropharyngeal mucosal erythema; prominent papillae creating a classic "strawberry tongue" .
Polymorphous Exanthem: Diffuse erythematous maculopapular rash, primarily on the trunk and perineum; non-vesicular.
Extremity Changes: Acute phase: Erythema of palms and soles with indurative, painful, non-pitting oedema of hands and feet. Convalescent phase (2–3 weeks post-onset): Characteristically distinct periungual sheet-like desquamation (peeling) extending from under the nails.
Cervical Lymphadenopathy: Typically unilateral, firm, non-purulent, measuring > 1.5 cm in diameter.
Caution
Incomplete (Atypical) Kawasaki Disease: Infants under 1 year often present atypically with fever for ≥ 5 days and fewer than 4 criteria, yet harbour the highest risk of developing giant coronary artery aneurysms. Any young infant with unexplained persistent fever and elevated inflammatory markers (CRP/ESR, thrombocytosis > 450 × 10⁹/L in the 2nd week) warrants urgent paediatric cardiology review and echocardiography.
Treatment Protocol
Intravenous Immunoglobulin (IVIG): Single high-dose infusion of 2 g/kg over 10–12 hours , ideally administered within the first 10 days of fever onset to abort coronary arterial inflammation.
High-Dose Aspirin: 30–50 mg/kg/day divided into 4 doses for its anti-inflammatory effects until the fever has resolved for 48 hours. This is one of the exceptionally rare clinical scenarios where aspirin is indicated in paediatric practice.
Maintenance Antiplatelet Aspirin: Following defervescence, stepped down to low-dose aspirin ( 3–5 mg/kg/day once daily ) for 6–8 weeks (or indefinitely if coronary aneurysms develop) to prevent thrombosis.
Baseline & Surveillance Echocardiography: Performed at diagnosis, at 2 weeks, and at 6–8 weeks to screen for coronary ectasia or aneurysm formation.
Febrile Convulsions
A febrile convulsion is an epileptic seizure occurring in a child aged between 6 months and 5 years provoked by a febrile illness, without evidence of intracranial infection (e.g., meningitis, encephalitis) or prior unprovoked afebrile seizures. They occur in 2% to 5% of healthy young children.
Classification Feature Simple Febrile Seizure (~75%) Complex Febrile Seizure (~25%)
Seizure Semiology Generalized tonic-clonic; symmetrical motor involvement Focal motor features; unilateral limb twitching
Duration Lasts < 15 minutes (typically 1–3 minutes) Prolonged, lasting ≥ 15 minutes, or serial seizures
Recurrence Does not recur within 24 hours or within the same febrile illness Recurs within 24 hours or within the same febrile episode
Post-Ictal State Rapid complete neurological recovery within 1 hour Incomplete recovery, persistent drowsiness, or focal post-ictal deficit ( Todd's paresis )
Prognosis & Epilepsy Risk Recurrence rate ~30%; baseline risk of future epilepsy is ~1–2% (barely above general population 0.5–1%) Higher recurrence rate; future epilepsy risk increased to ~4–12%
Acute Management and Parental Reassurance
Emergency Resuscitation: Place child in the recovery position, clear airway, administer high-flow oxygen. If seizure activity continues beyond 5 minutes , administer buccal midazolam (0.5 mg/kg) or rectal diazepam.
Investigation: Identify and treat the primary febrile focus (otitis media, viral tonsillitis, UTI). If the child is under 12 months, or if recovery is delayed, carefully exclude central nervous system infection with a lumbar puncture.
Safety-Netting: Reassure parents that simple febrile seizures do not cause brain damage, intellectual disability, or death. Provide verbal and written instructions on seizure first aid and emergency ambulance activation if a future seizure lasts longer than 5 minutes.